Activation of NF-κB/Rel by CD40 Engagement Induces the Mouse Germ Line Immunoglobulin Cγ1 Promoter

REFERENCES

• Allen, R. C., R. J. Armitage, M. E. Conley, H. Rosenblatt, N. A. Jenkins, N. G. Copeland, M. A. Bedell, S. Edelhoff, C. M. Disteche, D. K. Simoneaux, W. C. Fanslow, J. Belmont, and M. K. Spriggs. 1993. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259:990–993.
   PubMed Web of Science ®Google Scholar
• Aruffo, A., M. Farrington, D. Hollenbaugh, X. Li, A. Milatovich, S. Nonoyama, J. Bajorath, L. Grosmaire, R. Stenkamp, M. Neubauer, R. Roberts, R. Noelle, J. Ledbetter, U. Franke, and H. Ochs. 1993. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72:291–300.
   PubMed Web of Science ®Google Scholar
• Ballard, D. W., W. H. Walker, S. Doerre, P. Sista, J. A. Molitor, E. P. Dixon, N. J. Peffer, M. Hannink, and W. C. Greene. 1990. The v-rel oncogene encodes a κB enhancer binding protein that inhibits NF-κB function. Cell 63:803–814.
   PubMed Web of Science ®Google Scholar
• Banchereau, J., F. Bazan, D. Blanchard, F. Briere, J. P. Galizzi, C. V. Kooten, Y. J. Liu, F. Rousset, and S. Saeland. 1994. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:881–922.
   PubMed Web of Science ®Google Scholar
• Beg, A. A., T. S. Finco, P. V. Nantermet, and A. S. Baldwin, Jr. 1993. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα a mechanism for NF-κB activation. Mol. Cell. Biol. 13:3301–3310.
   PubMed Web of Science ®Google Scholar
• Beg, A. A., W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature (London) 376:167–170.
   PubMed Web of Science ®Google Scholar
• Berberich, I., G. L. Shu, and E. A. Clark. 1994. Cross-linking CD40 on B cells rapidly activates nuclear factor-κB. J. Immunol. 153:4357–4366.
   PubMed Web of Science ®Google Scholar
• Berton, M. T., and L. A. Linehan. 1995. IL-4 activates a latent DNA-binding factor that binds a shared IFN-γ and IL-4 response element present in the germ-line γ1 Ig promoter. J. Immunol. 154:4513–4525.
   PubMedGoogle Scholar
• Berton, M. T., J. W. Uhr, and E. Vitetta. 1989. Synthesis of germline γ1 immunoglobulin heavy-chain transcripts in resting B cells: induction by interleukin 4 and inhibition by interferon γ. Proc. Natl. Acad. Sci. USA 86:2829–2833.
   PubMed Web of Science ®Google Scholar
• Berton, M. T., and E. S. Vitetta. 1990. Interleukin 4 induces changes in the chromatin structure of the γ1 switch region in resting B cells before switch recombination. J. Exp. Med. 172:375–378.
   PubMedGoogle Scholar
• Bottaro, A., R. Lansford, L. Xu, J. Zhang, P. Rothman, and F. Alt. 1994. I region transcription (per se) promotes basal IgE class switch recombination but additional factors regulate the efficiency of the process. EMBO J. 13:665–674.
   PubMed Web of Science ®Google Scholar
• Brasier, A., J. Tate, and J. Habener. 1989. Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. BioTechniques 7:1116–1122.
   PubMed Web of Science ®Google Scholar
• Bull, P., K. L. Morley, M. F. Hoekstra, T. Hunter, and I. M. Verma. 1990. The mouse c-rel protein has an N-terminal regulatory domain and a C-terminal transcriptional transactivation domain. Mol. Cell. Biol. 10:5473–5485.
   PubMedGoogle Scholar
• Castigli, E., F. W. Alt, L. Davidson, A. Bottaro, E. Mizoguchi, A. K. Bhan, and R. S. Geha. 1994. CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc. Natl. Acad. Sci. USA 91:12135–12139.
   PubMed Web of Science ®Google Scholar
• Castle, B. E., K. Kishimoto, C. Stearns, M. L. Brown, and M. R. Kehry. 1993. Regulation of expression of the ligand for CD40 on T helper lymphocytes. J. Immunol. 151:1777–1788.
   PubMed Web of Science ®Google Scholar
• Choi, M. S., R. D. Brines, M. J. Holman, and G. G. Klaus. 1994. Induction of NF-AT in normal B lymphocytes by anti-immunoglobulin or CD40 ligand in conjunction with IL-4. Immunity 1:179–197.
   PubMed Web of Science ®Google Scholar
• Clark, E. A., and G. Shu. 1990. Association between IL-6 and CD40 signaling. IL-6 induces phosphorylation of CD40 receptors. J. Immunol. 145:1400–1406.
   PubMed Web of Science ®Google Scholar
• Delphin, S. A., and J. Stavnezer. 1995. Characterization of an IL-4 responsive region in the immunoglobulin heavy chain ɛ promoter: regulation by NF-IL4, a C/EBP family member and NF-κB/p50. J. Exp. Med. 181:181–192.
   PubMed Web of Science ®Google Scholar
• DiSanto, J. P., J. Y. Bonnefoy, J. F. Gauchat, A. Fischer, and G. de-Saint-Basile. 1993. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature (London) 361:541–543.
   PubMed Web of Science ®Google Scholar
• Dobrzanski, P., R. P. Ryseck, and R. Bravo. 1993. Both N- and C-terminal domains of RelB are required for full transactivation: role of the N-terminal leucine zipper-like motif. Mol. Cell. Biol. 13:1572–1582.
   PubMedGoogle Scholar
• Dobrzanski, P., R. P. Ryseck, and R. Bravo. 1994. Differential interactions of Rel-NF-κB complexes with IκBα determine pools of constitutive and inducible NF-κB activity. EMBO J. 13:4608–4616.
   PubMedGoogle Scholar
• Doerre, S., P. Sista, S.-C. Sun, D. W. Ballard, and W. C. Greene. 1993. The c-rel protooncogene product represses NF-κB p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 90:1023–1027.
   PubMedGoogle Scholar
• Du, W., D. Thanos, and T. Maniatis. 1993. Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements. Cell 74:887–898.
   PubMed Web of Science ®Google Scholar
• Esser, C., and A. Radbruch. 1989. Rapid induction of transcription of unrearranged Sγ1 switch regions in activated murine B cells by interleukin 4. EMBO J. 8:483–488.
   PubMedGoogle Scholar
• Fanslow, W. C., D. M. Anderson, K. H. Grabstein, E. A. Clark, D. Cosman, and R. J. Armitage. 1992. Soluble forms of CD40 inhibit biologic responses of human B cells. J. Immunol. 149:655–660.
   PubMed Web of Science ®Google Scholar
• Finco, T. S., and A. S. Baldwin. 1995. Mechanistic aspects of NF-κB regulation: the emerging role of phosphorylation and proteolysis. Immunity 3:263–272.
   PubMed Web of Science ®Google Scholar
• Francis, D. A., J. G. Karras, X. Y. Ke, R. Sen, and T. L. Rothstein. 1995. Induction of the transcription factors NF-κB, AP-1 and NF-AT during B cell stimulation through the CD40 receptor. Int. Immunol. 7:151–161.
   PubMed Web of Science ®Google Scholar
• Fujieda, S., K. Zhang, and A. Saxon. 1995. IL-4 plus CD40 mAb induces human B cells gamma subclass specific isotype switch: switching to γ1, γ3, γ4 but not γ2. J. Immunol. 155:2318–2328.
   PubMed Web of Science ®Google Scholar
• Fujita, K., M. D. Jumper, K. Meek, and P. E. Lipsky. 1995. Evidence for a CD40 responsive element, distinct from the IL-4 responsive element, in the germline ɛ promoter. Int. Immunol. 7:1529–1533.
   PubMedGoogle Scholar
• Fuleihan, R., N. Ramesh, R. Loh, H. Jabara, R. S. Rosen, T. Chatila, S. M. Fu, I. Stamenkovic, and R. S. Geha. 1993. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc. Natl. Acad. Sci. USA 90:2170–2173.
   PubMed Web of Science ®Google Scholar
• Ganchi, P. A., S. C. Sun, W. C. Greene, and D. W. Ballard. 1993. A novel NF-κB complex containing p65 homodimers: implications for transcriptional control at the level of subunit dimerization. Mol. Cell. Biol. 13:7826–7835.
   PubMedGoogle Scholar
• Gascan, H., J.-F. Gauchat, G. Aversa, P. van Vlasselaer, and J. E. De Vries. 1991. Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways. J. Immunol. 147:8–13.
   PubMed Web of Science ®Google Scholar
• Gauchat, J.-F., G. Aversa, H. Gascan, and J. E. de Vries. 1992. Modulation of IL-4 induced germline ɛ RNA synthesis in human B cells by tumor necrosis factor-α, anti-CD40 monoclonal antibodies or transforming growth factor-β correlates with levels of IgE production. Int. Immunol. 4:397–406.
   PubMed Web of Science ®Google Scholar
• Gauchat, J.-F., D. A. Lebmen, R. L. Coffman, H. Gascan, and J. E. deVries. 1990. Structure and expression of germline ɛ transcripts in human B cells induced by interleukin 4 to switch to IgE production. J. Exp. Med. 172:463–473.
   PubMed Web of Science ®Google Scholar
• Ghosh, S., A. M. Gifford, L. R. Riviere, P. Tempst, G. Nolan, and D. Baltimore. 1990. Cloning of the p50 DNA binding subunit of NF-κB: homology to rel and dorsal. Cell 62:1019–1029.
   PubMed Web of Science ®Google Scholar
• Glimcher, L. H., T. Hamano, R. Asofsky, E. Heber-Katz, R. H. Schwartz, and W. E. Paul. 1982. I region-restricted antigen presentation by B cell-B lymphoma hybridomas. Nature (London) 298:283–286.
   PubMedGoogle Scholar
• Harriman, G. R., A. Bradley, S. Das, P. Rogers-Fani, and A. C. Davis. 1996. IgA class switch in Iα exon deficient mice. Role of germline transcription in class switch recombination. J. Clin. Invest. 97:477–485.
   PubMedGoogle Scholar
• Hasbold, J., C. Johnson-Leger, C. J. Atkins, E. A. Clark, and G. G. Klaus. 1994. Properties of mouse CD40: cellular distribution of CD40 and B cell activation by monoclonal anti-mouse CD40 antibodies. Eur. J. Immunol. 24:1835–1842.
   PubMedGoogle Scholar
• Hasbold, J., and G. B. Klaus. 1994. B cells from CBA/N mice do not proliferate following ligation of CD40. Eur. J. Immunol. 24:152–157.
   PubMedGoogle Scholar
• Henkel, T., T. Machleidt, I. Alkalay, M. Kronke, Y. Ben-Neriah, and P. A. Baeuerle. 1993. Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB. Nature (London) 365:182–185.
   PubMed Web of Science ®Google Scholar
• Hohmann, H. P., R. Remy, B. Poschl, and A. P. van-Loon. 1990. Tumor necrosis factors-α and -β bind to the same two types of tumor necrosis factor receptors and maximally activate the transcription factor NF-κB at low receptor occupancy and within minutes after receptor binding. J. Biol. Chem. 265:15183–15188.
   PubMedGoogle Scholar
• Hou, J., U. Schindler, W. J. Henzel, T. C. Ho, M. Brasseur, and S. L. McKnight. 1994. An interleukin-4-induced transcription factor: IL-4 Stat. Science 265:1701–1706.
   PubMed Web of Science ®Google Scholar
• Huo, L., and T. L. Rothstein. 1995. Receptor-specific induction of individual AP-1 components in B lymphocytes. J. Immunol. 154:3300–3309.
   PubMed Web of Science ®Google Scholar
• Jabara, H. H., S. M. Fu, R. S. Geha, and D. Vercelli. 1990. CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J. Exp. Med. 172:1861–1864.
   PubMed Web of Science ®Google Scholar
• Jain, J., P. G. McCaffrey, V. E. Valge-Archer, and A. Rao. 1992. Nuclear factor of activated T cells contains fos and jun. Nature (London) 356:801–804.
   PubMedGoogle Scholar
• Jung, S., K. Rajewsky, and A. Radbruch. 1993. Shutdown of class switch recombination by deletion of a switch region control element. Science 259:984–987.
   PubMed Web of Science ®Google Scholar
• Kawabe, T., T. Naka, K. Yoshida, T. Tanaka, H. Fujiwara, S. Suematsu, N. Yoshida, T. Kishimoto, and H. Kikutani. 1994. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1:167–178.
   PubMed Web of Science ®Google Scholar
• Kearney, J. F., and A. R. Lawton. 1975. B lymphocyte differentiation induced by lipopolysaccharide. I. Generation of cells synthesizing four major immunoglobulin classes. J. Immunol. 115:671–676.
   PubMed Web of Science ®Google Scholar
• Kim, J., R. Reeves, P. Rothman, and M. Boothby. 1995. The non-histone chromosomal protein HMG-I(Y) contributes to the repression of the immunoglobulin heavy chain germ-line ɛ promoter. Eur. J. Immunol. 25:798–808.
   PubMed Web of Science ®Google Scholar
• Kitani, A., and W. Strober. 1993. Regulation of Cγ subclass germ-line transcripts in human peripheral blood B cells. J. Immunol. 151:3478–3488.
   PubMed Web of Science ®Google Scholar
• Kohler, I., and E. P. Rieber. 1993. Allergy-associated Iε and Fcε receptor II (CD23b) genes activated via binding of an interleukin-4-induced transcription factor to a novel responsive element. Eur. J. Immunol. 23:3066–3071.
   PubMedGoogle Scholar
• Köntge, F., R. J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlinton, and S. Gerondakis. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9:1965–1977.
   PubMedGoogle Scholar
• Kopp, E. B., and S. Ghosh. 1995. NF-κB and rel proteins in innate immunity. Adv. Immunol. 58:1–27.
   PubMed Web of Science ®Google Scholar
• Körthauer, U., D. Graf, H. W. Mages, F. Briere, M. Padayachee, S. Malcolm, A. G. Ugazio, L. D. Notarangelo, R. J. Levinsky, and R. A. Kroczek. 1993. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature (London) 361:539–541.
   PubMed Web of Science ®Google Scholar
• Kühn, R., K. Rajewsky, and W. Müller. 1991. Generation and analysis of interleukin-4 deficient mice. Science 254:707–710.
   PubMed Web of Science ®Google Scholar
• Lalmanach-Girard, A.-C., T. C. Chiles, D. C. Parker, and T. L. Rothstein. 1993. T cell-dependent induction of NF-κB in B cells. J. Exp. Med. 177:1215–1219.
   PubMed Web of Science ®Google Scholar
• Lane, P., T. Brocker, S. Hubele, E. Padovan, A. Lanzavecchia, and F. McConnell. 1993. Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation. J. Exp. Med. 177:1209–1213.
   PubMed Web of Science ®Google Scholar
• Lane, P., A. Traunecker, S. Hubele, S. Inui, A. Lanzavecchia, and D. Gray. 1992. Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur. J. Immunol. 22:2573–2580.
   PubMed Web of Science ®Google Scholar
• Lebman, D. A., D. Y. Nomura, R. L. Coffman, and F. D. Lee. 1990. Molecular characterization of germ-line immunoglobulin A transcripts produced during transforming growth factor type β-induced isotype switching. Proc. Natl. Acad. Sci. USA 87:3962–3966.
   PubMed Web of Science ®Google Scholar
• Lernbecher, T., B. Kistler, and T. Wirth. 1994. Two distinct mechanisms contribute to the constitutive activation of RelB in lymphoid cells. EMBO J. 13:4060–4069.
   PubMedGoogle Scholar
• Liao, F., B. Birshtein, M. Busslinger, and P. Rothman. 1994. The transcription factor BSAP (NF-HB) is essential for immunoglobulin germ-line s transcription. J. Immunol. 152:2904–2911.
   PubMedGoogle Scholar
• Lin, S.-C., H. Wortis, and J. Stavnezer. Unpublished data.
   Google Scholar
• Lin, Y.-C. A., and J. Stavnezer. 1992. Regulation of transcription of the germline Iga constant region gene by an ATF element and by novel transforming growth factor-β1-responsive elements. J. Immunol. 149:2914–2925.
   PubMed Web of Science ®Google Scholar
• Liou, H.-C., W. C. Sha, M. L. Scott, and D. Baltimore. 1994. Sequential induction of NF-κB/Rel family proteins during B-cell terminal differentiation. Mol. Cell. Biol. 14:5349–59.
   PubMed Web of Science ®Google Scholar
• Lorenz, M., S. Jung, and A. Radbruch. 1995. Switch transcripts in immunoglobulin class switching. Science 267:1825–1828.
   PubMedGoogle Scholar
• Lundgren, M., C. Larrson, A. Femino, M. Xu, J. Stavnezer, and E. Severinson. 1994. Activation of the Ig germ-line γ1 promoter: involvement of C/EBP transcription factors and their possible interaction with a NF-IL4 site. J. Immunol. 153:2983–2995.
   PubMedGoogle Scholar
• Lutzker, S., P. Rothman, R. Pollock, R. Coffman, and F. W. Alt. 1988. Mitogen- and IL-4-regulated expression of germline Igγ2b transcripts: evidence for directed heavy chain class switching. Cell 53:177–184.
   PubMed Web of Science ®Google Scholar
• Miyamoto, S., and I. M. Verma. 1995. Rel/NF-κB/IκB story. Adv. Cancer Res. 66:255–292.
   PubMed Web of Science ®Google Scholar
• Neumann, J. R., C. A. Morency, and K. O. Russian. 1987. A novel rapid assay for chloramphenicol acetyl transferase gene expression. BioTech-niques 5:444–447.
   Web of Science ®Google Scholar
• Noelle, R. J., M. Roy, D. M. Shepherd, I. Stamenkovic, J. A. Ledbetter, and A. Aruffo. 1992. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc. Natl. Acad. Sci. USA 89:6550–6554.
   PubMed Web of Science ®Google Scholar
• Nolan, G. P., S. Ghosh, H. C. Liou, P. Tempst, and D. Baltimore. 1991. DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptide. Cell 64:961–969.
   PubMed Web of Science ®Google Scholar
• Parker, D. C. 1993. T cell-dependent B cell activation. Annu. Rev. Immunol. 11:331–360.
   PubMed Web of Science ®Google Scholar
• Pierce, J. W., C. A. Jamieson, J. L. Ross, and R. Sen. 1995. Activation of IL-2 receptor α-chain gene by individual members of the rel oncogene family in association with serum response factor. J. Immunol. 155:1972–1980.
   PubMedGoogle Scholar
• Purkerson, J. M., M. Newberg, G. Wise, K. R. Lynch, and P. C. Isakson. 1988. Interleukin 5 and interleukin 2 cooperate with interleukin 4 to induce IgG1 secretion from anti-Ig-treated B cells. J. Exp. Med. 168:1175–1180.
   PubMedGoogle Scholar
• Quelle, F. W., K. Shimoda, W. Thierfelder, C. Fischer, A. Kim, S. M. Ruben, J. L. Cleveland, J. H. Pierce, A. D. Keegan, K. Nelms, W. E. Paul, and J. N. Ihle. 1995. Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to interleukin-4 (IL-4) and IL-3 but are not required for mitogenesis. Mol. Cell. Biol. 15:3336–3343.
   PubMed Web of Science ®Google Scholar
• Rice, N. R., and M. K. Ernst. 1993. In vivo control of NF-κB activation by IκBα. EMBO J. 12:4685–4695.
   PubMedGoogle Scholar
• Rothman, P., S. C. Li, B. Gorham, L. Glimcher, F. W. Alt, and M. Boothby. 1991. Identification of a conserved lipopolysaccharide-plus-interleukin-4-responsive element located at the promoter of germline s transcripts. Mol. Cell. Biol. 11:5551–5561.
   PubMed Web of Science ®Google Scholar
• Rothman, P., S. Lutzker, W. Cook, R. Coffman, and F. W. Alt. 1988. Mitogen plus interleukin 4 induction of Cε transcripts in B lymphoid cells. J. Exp. Med. 168:2385–2389.
   PubMedGoogle Scholar
• Ryseck, R. P., P. Bull, M. Takamiya, V. Bours, U. Siebenlist, P. Dobrzanski, and R. Bravo. 1992. RelB, a new Rel family transcription activator that can interact with p50-NF-κB. Mol. Cell. Biol. 12:674–684.
   PubMedGoogle Scholar
• Schindler, U., and V. R. Baichwal. 1994. Three NF-κB binding sites in the human E-selectin gene required for maximal tumor necrosis factor α-in-duced expression. Mol. Cell. Biol. 14:5820–5831.
   PubMed Web of Science ®Google Scholar
• Schmitz, J., and A. Radbruch. 1989. An interleukin 4-induced DNase I hypersensitive site indicates opening of the γ1 switch region prior to switch recombination. Int. Immunol. 1:570–575.
   PubMedGoogle Scholar
• Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer proteins with ‘mini-extracts’, prepared from a small number of cells. Nucleic Acids Res. 17:6419.
   PubMed Web of Science ®Google Scholar
• Schultz, C. L., P. Rothman, R. Kuhn, M. Kehry, W. Muller, K. Rajewsky, F. Alt, and R. L. Coffman. 1992. T helper cell membranes promote IL-4-independent expression of germ-line Cγ1 transcripts in B cells. J. Immunol. 149:60–64.
   PubMedGoogle Scholar
• Severinson, E., C. Fernandez, and J. Stavnezer. 1990. Induction of germline immunoglobulin heavy chain transcripts by mitogens and interleukins prior to switch recombination. Eur. J. Immunol. 20:1079–1084.
   PubMed Web of Science ®Google Scholar
• Sha, W. C., H.-C. Liou, E. I. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80:321–330.
   PubMed Web of Science ®Google Scholar
• Shockett, P., and J. Stavnezer. 1991. Effect of cytokines on switching to IgA and α germline transcripts in the B lymphoma I.29µ: transforming growth factor-β activates transcription of the unrearranged Cα gene. J. Immunol. 147:4374–4383.
   PubMedGoogle Scholar
• Snapper, C. M., M. R. Kehry, B. E. Castle, and J. J. Mond. 1995. Multivalent, but not divalent, antigen receptor cross-linkers synergize with CD40 ligand for induction of Ig synthesis and class switching in normal murine B cells. J. Immunol. 154:1177–1187.
   PubMed Web of Science ®Google Scholar
• Snapper, C. M., T. M. McIntyre, R. Mandler, L. M. T. Pecanha, F. D. Finkelman, A. Lees, and J. J. Mond. 1992. Induction of IgG3 secretion by interferon γ: a model for T cell-independent class switching in response to T cell-independent type 2 antigens. J. Exp. Med. 175:1367–1371.
   PubMed Web of Science ®Google Scholar
• Snapper, C. M., L. M. T. Pecanha, A. D. Levine, and J. J. Mond. 1991. IgE class switching is critically dependent upon the nature of the B cell activator, in addition to the presence of IL-4. J. Immunol. 147:1163–1170.
   PubMed Web of Science ®Google Scholar
• Snapper, C. M., P. Zelazowski, F. R. Rosas, M. R. Kehry, M. Tian, D. Baltimore, and W. C. Sha. 1996. B cells from p50/NF-κB knockout mice have selective defects in proliferation, differentiation, germline CH transcription and Ig class switching. J. Immunol. 156:183–191.
   PubMedGoogle Scholar
• Stavnezer, J. 1996. Antibody class switching. Adv. Immunol. 61:79–146.
   PubMed Web of Science ®Google Scholar
• Stavnezer, J., G. Radcliffe, Y.-C. Lin, J. Nieutupski, L. Berggren, R. Sitia, and E. Severinson. 1988. Immunoglobulin heavy-chain switching may be directed by prior induction of transcripts from constant-region genes. Proc. Natl. Acad. Sci. USA 85:7704–7708.
   PubMed Web of Science ®Google Scholar
• Stavnezer-Nordgren, J., and S. Sirlin. 1986. Specificity of immunoglobulin heavy chain switch correlates with activity of germline heavy chain genes prior to switching. EMBO J. 5:95–102.
   PubMed Web of Science ®Google Scholar
• Thévenin, C., S. C. Kim, P. Rieckmann, H. Fujiki, M. A. Norcross, M. B. Sporn, and J. Kehrl. 1990. Induction of NF-κB and the human HIV long terminal repeat by okadaic acid, a specific inhibitor of phosphatases 1 and 2A. New Biol. 2:793–800.
   PubMedGoogle Scholar
• Thompson, J. E., R. J. Phillips, H. Erdjument-Bromage, P. Tempst, and S. Ghosh. 1995. IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell 80:573–582.
   PubMed Web of Science ®Google Scholar
• Traenckner, E. B.-M., S. Wilk, and P. A. Baeuerle. 1994. A proteasome inhibitor prevents phosphorylation of NF-κB and stabilizes a newly phos-phorylated form of IκBα that is still bound to NF-κB. EMBO J. 13:5433–5441.
   PubMed Web of Science ®Google Scholar
• van Ommen, R., A. E. Vredendaal, and H. F. Savelkoul. 1994. Suppression of polyclonal and antigen-specific murine IgG1 but not IgE responses by neutralizing interleukin-6 in vivo. Eur. J. Immunol. 24:1396–1403.
   PubMedGoogle Scholar
• Warren, W. D., and M. T. Berton. 1995. Induction of germline γ1 and ε Ig gene expression in murine B cells: interleukin 4 and the CD40 ligand-CD40 interaction provide distinct but synergistic signals. J. Immunol. 155:5637–5646.
   PubMedGoogle Scholar
• Weih, F., D. Carrasco, S. K. Durham, D. S. Barton, C. A. Rizzo, R. P. Ryseck, S. A. Lira, and R. Bravo. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell 80:331–340.
   PubMed Web of Science ®Google Scholar
• Wortis, H. (Tufts University School of Medicine). Unpublished data.
   Google Scholar
• Xu, J., T. M. Foy, J. D. Laman, E. A. Elliott, J. J. Dunn, T. J. Waldschmidt, J. Elsemore, R. J. Noelle, and R. A. Flavell. 1994. Mice deficient for the CD40 ligand. Immunity 1:423–432.
   PubMed Web of Science ®Google Scholar
• Xu, M., and J. Stavnezer. 1992. Regulation of transcription of immunoglobulin germ-line γ1 RNA: analysis of the promoter/enhancer. EMBO J. 11:145–155.
   PubMedGoogle Scholar
• Zhang, J., A. Bottaro, S. Li, V. Stewart, and F. W. Alt. 1993. A selective defect in IgG2b switching as a result of targeted mutation of the Iγ2b promoter and exon. EMBO J. 12:3529–3537.
   PubMedGoogle Scholar